Sort by
Refine Your Search
-
, Alzheimer’s, and sickle cell disease, while also applying our techniques to molecular dynamics simulations of proteins and complexes. As a successful candidate, you will: Develop novel probabilistic network
-
. Requirements: Recent Ph.D. graduate in physics, chemistry, materials science, bioinformatics, computational science, or a related discipline. Strong understanding of Molecular Dynamics simulations and
-
to appoint a postdoctoral fellows in April 2024. We are looking for candidates with interests in the cross section of atomic molecular optical physics and quantum simulation and computation Candidates should
-
molecular modeling and simulation is an advantage. Amgens biophysical NMR facilities are equipped with Bruker 500, 600, and 800 MHz instruments with cryoprobes and SampleJets. Other Biohysical methods
-
of heterogeneous reactions, to study ionic diffusion in complex inorganic and polymer electrolytes. Methods will combine first principles, molecular dynamics, enhanced sampling, and stochastic simulations with state
-
://yehlab.labsites.cshl.edu ). We are recruiting new members passionate about drug discovery and chemical biology. Our lab is working to understand the molecular mechanisms leading to efficient elicitation of tumor
-
home in the Department of Exercise Science alongside a dynamic group of scholars. With the additional support of USC’s Office of Access and Opportunity and Provost’s Office, Faculty Fellows will have
-
appointment at USC at the start of the 2026-2027 academic year. As a member of the 2nd cohort of Bridge to Faculty Fellows from across the university, the Fellow will have a home in DDBS alongside a dynamic
-
computational and molecular biology. The Levy and Wigler research groups are re-envisioning the tools of genetics research by coupling innovation at the bench with novel computational methods. We have developed
-
discovery and chemical biology. Our lab is working to understand the molecular mechanisms leading to efficient elicitation of tumor vulnerability for potent cancer targeting. We develop Targeted Protein